首页> 外国专利> PHARMACEUTICAL COMPOSITION COMPRISING AZATHIOPRINE AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING BRAIN TUMORS OR TEMODAL-RESISTANT GLIOBLASTOMAS

PHARMACEUTICAL COMPOSITION COMPRISING AZATHIOPRINE AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING BRAIN TUMORS OR TEMODAL-RESISTANT GLIOBLASTOMAS

机译:包含AZATHIOPRINE的药物组合物,作为预防或治疗脑肿瘤或抗模态性胶质母细胞增生的有效成分

摘要

The present invention relates to a pharmaceutical composition for the prevention or treatment of cancer or Temodal resistant glioblastoma multiform comprising azathioprine as an active ingredient. The azathioprine of the present invention is not only effective in inhibiting the growth of glioblastoma multiform, a kind of brain tumor, but also excellent in treating glioblastoma multiform that displays resistance against Temodal (temozolomide), the conventional therapeutic agent for glioblastoma multiform, so that it can be effectively used as an active ingredient of a pharmaceutical composition for the prevention or treatment of such cancer as brain tumor (particularly, glioblastoma multiform) and particularly Temodal resistant glioblastoma multiform.
机译:本发明涉及用于预防或治疗癌症或Temodal抗性胶质母细胞瘤形式的药物组合物,其包含硫唑嘌呤作为活性成分。本发明的硫唑嘌呤不仅有效抑制一种形式的脑肿瘤胶质母细胞瘤的生长,而且对表现出对胶质母细胞瘤传统形式的治疗剂Temodal(替莫唑胺)表现出抗性的胶质母细胞瘤具有优异的治疗效果,因此它可以有效地用作药物组合物的活性成分,以预防或治疗诸如脑肿瘤(特别是多形性胶质母细胞瘤),特别是四峰抗性多形性胶质母细胞瘤的癌症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号